Published by
@ShahidNShah
@ShahidNShah
April 16 to April 18, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The updated ICH Q14 guidance by the FDA has raised the bar for product quality expectations in release and stability testing. The 3rd ADC Analytical Development conference, scheduled for Tue, 16 Apr 2024 - Thu, 18 Apr 2024, addresses this evolution. It offers a technical exploration into optimizing physiochemical methods to quantify drug-to-antibody ratio (DAR) and distribution, size and charge variants, bioassays for potency understanding, and impurity assays. Engage with 100+ experts from leading organizations like Daiichi Sankyo, Eli Lilly, and AstraZeneca to gain comprehensive insights for producing high-quality, regulatory-compliant antibody-drug conjugates (ADCs). This event fosters collaboration, addresses analytical challenges, and navigates future regulatory clarity for ADC experts.
[Read on adc-analytical.com](https://adc-analytical.com/)
Continue reading at adc-analytical.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 6:20am